Author | Charles F. Shaefer Jr, MD

Articles

ADA Posters: Incretins, SGLT2s, and New Fixed-dose Combos

June 19, 2014

Article

Posters at ADA 2014 showcased growing popularity of the incretin therapies and SGLT2 inhibitors. Most fascinating to this diabetologist blogger was use of insulin and a GLP-1 RA in a fixed-combination product.